These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3511551)

  • 1. Thyroid carcinoma.
    Bell RM
    Surg Clin North Am; 1986 Feb; 66(1):13-30. PubMed ID: 3511551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Postoperative follow-up in differentiated carcinoma of the thyroid gland].
    Pandolfi C
    Minerva Med; 1986 Jun; 77(27):1317-9. PubMed ID: 3725155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma.
    Giovanella L; Ceriani L; Ghelfo A; Keller F
    Clin Chem Lab Med; 2005; 43(8):843-7. PubMed ID: 16201895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Well-differentiated thyroid neoplasia: a curable cancer.
    Ferguson CM
    J Med Assoc Ga; 1988 Nov; 77(11):846-9. PubMed ID: 3057101
    [No Abstract]   [Full Text] [Related]  

  • 6. Thyroid cancer: some basic considerations.
    Wanebo HJ; Andrews W; Kaiser DL
    Am J Surg; 1981 Oct; 142(4):474-9. PubMed ID: 7283050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroglobulin-guided (131)I ablation in low-risk differentiated thyroid carcinoma: is the yardstick accurate enough?
    Giovanella L
    Head Neck; 2011 Sep; 33(9):1379-80; author reply 1380-1. PubMed ID: 21739512
    [No Abstract]   [Full Text] [Related]  

  • 8. The indications for ablating normal thyroid tissue with 131I in differentiated thyroid cancer.
    Goolden AW
    Clin Endocrinol (Oxf); 1985 Jul; 23(1):81-6. PubMed ID: 3896581
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of postoperative 131I treatment on thyroglobulin measurements in the follow-up of patients with thyroid cancer.
    Baskin HJ
    Thyroid; 1994; 4(3):239-42. PubMed ID: 7833657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is radioiodine ablation necessary for patients with low-risk papillary thyroid carcinoma and tumor >4 cm?
    Rosario PW
    Eur J Surg Oncol; 2017 Sep; 43(9):1802-1803. PubMed ID: 28743373
    [No Abstract]   [Full Text] [Related]  

  • 11. Postsurgical management of differentiated thyroid carcinoma.
    Mazzaferri EL; Robyn J
    Otolaryngol Clin North Am; 1996 Aug; 29(4):637-62. PubMed ID: 8844735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant therapy with 131-iodine in patients with elevated serum thyroglobulin after reoperation due to papillary thyroid carcinoma lymph node metastases.
    Rosario PW; Mourão GF; Siman TL; Calsolari MR
    Endocrine; 2015 May; 49(1):279-82. PubMed ID: 25205448
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prognostically relevant factors in follicular thyroid cancer].
    Böttger T; Klupp J; Sorger K; Junginger T
    Langenbecks Arch Chir; 1990; 375(5):266-71. PubMed ID: 2259260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Total thyroidectomy without radioiodine ablation for low-risk thyroid cancer].
    Dralle H
    Chirurg; 2016 Aug; 87(8):698. PubMed ID: 27299751
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prospective therapy study in differentiated thyroid carcinoma].
    Gemsenjäger E; Heitz P; Martina B
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary: Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.
    Terris DJ
    Head Neck; 2010 Jun; 32(6):698-9. PubMed ID: 20187017
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of total thyroidectomy in the management of differentiated thyroid cancer.
    Stephenson BM; Wheeler MH; Clark OH
    Curr Opin Gen Surg; 1994; ():53-9. PubMed ID: 7584009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
    Linder R; Fuhrmann J; Hammerschmidt D
    Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.